minocyclineinsulinIL-1RAglucocorticoidsDKA
…nterventions to modify MMPs during DKA, for example, the use of minocycline, which is a potent inhibitor of MMP-9, may represent important …
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…nterventions to modify MMPs during DKA, for example, the use of minocycline, which is a potent inhibitor of MMP-9, may represent important …